SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences: The Wells Fargo 2026 Healthcare Conference, which is being held in Boston, MA from September 8-10, 2026. Management is scheduled to participate in a fireside chat on Thursday, September 10th at 8:45 a.m. Eastern Time. The Baird 2026 Global Healthcare
MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.
In August 2026, Merit Medical Systems announced that Sheri Lewis would join as Executive Vice President of Global Operations, bringing three decades of global manufacturing and supply chain experience from SkinHealth Systems, Avantor, Medtronic, and Honeywell, while long-time operations leader Mr. Peterson shifted to a Senior Advisor role through March 2027 to support continuity. This leadership transition highlights Merit's focus on strengthening global operations and supply chain...
Why this leadership change at Merit Medical Systems matters for investors Merit Medical Systems (MMSI) recently announced that Sheri Lewis will become Executive Vice President of Global Operations on August 31, 2026, with long time operations leader Mr. Peterson shifting to a Senior Advisor role. For you as an investor, this type of operational leadership change can influence how effectively the company runs its global manufacturing footprint and manages costs. It can also shape how resilient...
Detailed price information for Chord Energy Corp (CHRD-Q) from The Globe and Mail including charting and trades.
SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as Executive Vice President of Global Operations, effective August 31, 2026. Ms. Lewis brings three decades of experience across global operations, manufacturing, and supply chain management. She previously held senior roles at SkinHealth Systems, Inc., Avantor, Medtronic, and Honeywell,
Merit Medical Systems (MMSI) said late Wednesday that Chief Operating Officer Neil Peterson will tra
Detailed price information for Nutanix Inc (NTNX-Q) from The Globe and Mail including charting and trades.
Merit Medical Systems (NASDAQ:MMSI) is focused on completing the objectives of its current long-range plan while developing its next strategic framework, Chief Financial Officer and Treasurer Raul Parra said during a Canaccord investor event. Parra said the company remains “hyper-focused” on execut
Merit Medical Systems (NASDAQ:MMSI) is preparing its next long-range plan as the medical-device company works through a leadership transition, updates its reporting structure and seeks to build on recent revenue and margin momentum. Speaking at Bank of America’s virtual SMID Cap event, Chief Financ
Detailed price information for Merit Medical Sys (MMSI-Q) from The Globe and Mail including charting and trades.
Motley Fool Press Release.
Neil W. Peterson, Chief Operating Officer, on August 04, 2026, sold 21,449 shares in Merit Medical S
SOUTH JORDAN, Utah, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today...
Detailed price information for Artivion Inc (AORT-N) from The Globe and Mail including charting and trades.
Merit Medical Systems (MMSI) is back in focus after releasing second quarter 2026 results and raising its full year outlook, with updated guidance reflecting stronger than expected performance in the first half. See our latest analysis for Merit Medical Systems. Merit Medical Systems’ recent earnings release and higher 2026 guidance have coincided with building momentum, with a 30 day share price return of 22.4% and a 90 day share price return of 37.1%, while the 1 year total shareholder...
Merit Medical Systems Inc (NASDAQ: MMSI) reported strong Q2 earnings, beating estimates with raised guidance. Analysts maintain Buy ratings with increased price targets.
Merit Medical Systems (MMSI) has an average rating of overweight and mean price target of $99.18, ac
Moby summary of Merit Medical Systems, Inc.'s Q2 2026 earnings call
Merit Medical Systems (MMSI) has an average rating of overweight and mean price target of $98.36, ac
Merit Medical Systems Inc (MMSI) delivers 9% constant currency organic growth and 18% EPS increase, prompting upward revision of full-year 2026 outlook.
Merit Medical (MMSI) delivered earnings and revenue surprises of +23.96% and +3.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
The headline numbers for Merit Medical (MMSI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Medical device company Merit Medical Systems (NASDAQ:MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates.
Merit Medical Systems (MMSI) reported Q2 non-GAAP earnings late Thursday of $1.19 per share, up from
Detailed price information for Merit Medical Sys (MMSI-Q) from The Globe and Mail including charting and trades.
MMSI vs. WST: Which Stock Is the Better Value Option?
MMSI's portfolio, acquisitions, R&D strategy and WRAPSODY upside support growth, though tariffs, China pressure and OEM headwinds persist.
This is the newest page. Registered accounts read further back.